SA

Shahid Ali

School of Biology, Hunan University, Hainan University, South China University of Technology, Jamia Millia Islamia, Yeungnam University, University of Delhi

Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Computational Drug Discovery Methods · Muscle Physiology and Disorders · Enzyme Catalysis and Immobilization

ORCID iD 0000-0002-4724-5086

About

Dr. Shahid Ali is a Postdoctoral Fellow in the School of Biology at Hunan University, China, where his research centres on de novo peptide design for plant immunity and the engineering of synthetic receptor-like kinases. His current work combines generative protein design with all-atom molecular dynamics to build peptide agonists capable of engaging multi-receptor immune complexes — an approach aimed at producing biologically active molecules rather than computational predictions alone.

He trained as a botanist, holding a B.Sc. (Hons.) in Botany, before moving into computation with a Master's degree in Bioinformatics and a Ph.D. from the South China University of Technology, where his doctoral research addressed enzyme engineering and computational biology. This trajectory from organismal biology through to structural computation shapes his research style: he works on problems where the computational result must ultimately be answerable to experiment.

Prior to his current appointment, Dr. Ali was a Postdoctoral Researcher at the School of Cyberspace Security, Hainan University (2024–2026). Before that, he spent three years at Yeungnam University, Republic of Korea, in the Department of Medical Biotechnology, first as a Postdoctoral Researcher (2021–2022) and subsequently as a Research Professor (2022–2024), where he led projects, supervised graduate students, and coordinated collaborations with experimental groups.

His research spans structural bioinformatics, machine learning, molecular dynamics, and computer-aided drug discovery. He has developed graph neural network architectures — including graph attention and heterogeneous graph networks built on protein language model embeddings — paired with explainable AI methods to make model predictions interpretable rather than merely accurate. Alongside this, he maintains an active programme in virtual screening, binding free energy estimation, and protein engineering, with recent work on inhibitor discovery and the redesign of plant transport proteins.

Dr. Ali has published more than 30 peer-reviewed articles, which have attracted approximately 1,200 citations, giving him an h-index of 19 and an i10-index of 23. He holds six patents, including three granted in Korea and one PCT international filing, and has completed two technology transfers to industry through Neo Crema Co., Ltd. — outcomes he regards as the natural endpoint of computational work that is meant to be used.

He continues to work at the intersection of protein design, machine learning, and molecular simulation, with a particular interest in extending generative design methods to receptor systems of agricultural and therapeutic importance.

Employment

Education

Projects & Funding

Projects & funding information is unavailable.

Publications (27)